Pivot bio   final presentation
 

Pivot bio final presentation

on

  • 1,615 views

 

Statistics

Views

Total Views
1,615
Views on SlideShare
1,615
Embed Views
0

Actions

Likes
0
Downloads
7
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment
  • Updated business model canvas to reflect changes in value props and our discovery of actual customer segment. Moving foward, we wanted to test the product market fit of our core value propositions.

Pivot bio   final presentation Pivot bio final presentation Presentation Transcript

  • Probiotics for Agriculture December 10th, 2013 Total interviews: 75
  • The Pivot Team Karsten Temme CEO Alvin Tamsir CSO Emily Tung Researcher John Cumbers Mentor
  • Week 1 • • • Academic labs UC Davis Soil Ecology group • SynBerc AgBio industry leaders Science – lab POC Field trials Regulatory engagement Establish AgBio partnership for sales channels • Inoculant distribution • Customer service • Public relations • Reduced risk of loss in drought • Improved yield • Organic • Lower human and equipment costs • Direct relationships • Self service (3rd party purchases) • On-farm interactions • Potential collaborative relationships Dow Corning Bayer Monsanto TBD: - Fermentation scale up - Packaging and prep Farmers • Corn • Wheat • Rice Corporate farm Family farm • • • • • • Synthetic biology IP Next gen sequencing IP Proprietary microbes Regulatory awareness Sales staff Production staff and facility • Direct sales • Local supplier / grain elevator • Seed companies • Fertilizer companies • State fairs • Inoculant purchases • Next-gen sequencing diagnostic • Licensing royalties Organic Conventional
  • Crops Treatments GM Strains Natural Strains Probiotic Mixture Natural Strains • Germinated in sterile greenhouse conditions • CA dominates US tomato cultivation Fermented Metabolites
  • Week 1 • Reduced risk of loss in drought • Improved yield • Organic • Lower human and equipment costs Week 5 Farmers • Corn • Wheat • Rice • Tomato seed companies • Tomato nurseries Corporate farm Family farm Organic Conventional • Tomato farmers • Seed coating companies
  • Customer archetype • • • • Manager of HeinzSeed Global 60+ years of tomato seed breeding Develops most of top tomato varieties Looks for new technologies to improve tomato production Plant health Fruit quality Dale Smith HeinzSeed Disease resistance Yield Drought tolerance Germination
  • US Commercial Processing Tomato Industry Acreage: Location: Market Size: 300,000 acres 95% in CA $700M Break even: Average: Highest: 40 tons / acre 48 tons / acre 70 tons / acre “10% yield improvement would be significant”
  • Channels and Market Structure Product Flow Cash Flow Seed production Seed breeders Seed treatment Seed distributors Grading and Processing Nurseries Commercial Farms
  • The MVP Tomato Seeds Seed breeders Seed production 50% market Seed treatment Heinz Value based pricing Yield Increase - $70M Current $700M $10M Heinz + Pivot Value if MVP applied to Top 10 Varieties of 2013 $7.5M To Farmers - $35M $5M To Greenhouses - $4M To Seed Breeders - $3M Pivot (40%) - $28M $2.5M Red = Heinz varieties
  • Building the MVP: Key Metrics MVP Now Q1 2014 Q2 2014 Q3 2014 Greenhouse Trial Q4 2014 Field Trial R&D Activites Milestone Cost • Endophyte Isolation • 500 relevant strains $30k • Sequencing and Analytics • All genomes annotated and scored $50k • Selection and Optimization • 50 high confidence strains $140k • Greenhouse Trial • 10% yield increase $60k Personnel: 1 bioinformatician Partners (done): Greenhouse (UC Berkeley), NGS (Seqmatic), Heinz and Germains IP: File composition of matter on 50 high confidence strains Economics: Validate revenue sharing hypotheses, negotiate field trial financing
  • Week 10
  • Senior customer endorsement Operational plan validated Talent recruited IP strategy and KOL network “Proof of Relevance” defined Timeline and cost to data points Strategic fit in portfolio validated Technology confirmed First pass canvas